SCHEMBL18274483

SCHEMBL18274483

N#CC(c1ccc(F)cn1)N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ ACHE P22303 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ JAK2 O60674 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RPS6KB1 P23443 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18274477 0.85 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2ACHEKDM4EHSD17B10
SCHEMBL2784285 0.77 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL10749589 0.77 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL18274471 0.77 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL15797454 0.74 DPP4 (0.47) ACHEKDM4EJAK2KCNH2MAPT
SCHEMBL2782859 0.72 SLC6A2 (0.52) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL15797453 0.72 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KDM4EKCNH2MAPT
SCHEMBL16995086 0.72 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL18274496 0.71 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL20036442 0.71 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931717-B1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-12-07 — — EP disclosed
Send feedback